Participants in the 5:2 intermittent fasting group had better blood sugar levels and higher weight loss compared to those on standard diabetes drugs like metformin and empagliflozin.
The EARLY study on intermittent fasting involved 405 participants with Type 2 diabetes, showing a significant drop in HbA1c levels and notable weight loss over 16 weeks.
[
Collection
]
[
|
...
]